Pulmonary Diseases Completed Phase 1 Trials for Alunacedase alfa (DB15736)

Also known as: Disease, Pulmonary / Pulmonary Disease

IndicationStatusPhase
DBCOND0033751 (Pulmonary Diseases)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00886353Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)Treatment